| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |